Edward Walker
About Edward Walker
Edward Walker is the Director of Protein Therapeutics, specializing in the integration of computational data, robotics, and AI for drug discovery.
Edward Walker - Director of Protein Therapeutics
Edward Walker holds the position of Director of Protein Therapeutics. He specializes in the design of protein therapeutics, integrating computational and biological data, laboratory automation, and multimodal AI models for drug discovery. He collaborates with a team that leverages a state-of-the-art robotics-driven lab facility to scale wet lab assays and evaluate small and large molecules in various ADME assays.
Edward Walker's Education and Expertise
Edward Walker holds a Ph.D., underpinning his advanced expertise in the field of protein therapeutics. His specialization includes the design and implementation of computational and wet lab biological data, robotics-driven laboratory automation, and multimodal AI models for effective drug discovery. He actively addresses the challenges associated with small and large molecule drug discovery as part of an Input-Transform-Output platform team.
Edward Walker's Role in Drug Discovery
Edward Walker contributes significantly to drug discovery by evaluating small and large molecules using multiple ADME assays to determine drug-likeness. His role involves establishing PK/PD relationships and validating them in vivo for both small and large molecule candidates. He utilizes a multidisciplinary approach, combining robotics-driven laboratory automation with cutting-edge AI models to streamline the discovery process.
Edward Walker's Collaboration and Engagement Models
Edward Walker collaborates within a team that offers various engagement models, including Co-Discovery Partnerships, Co-Engineering Partnerships, Platform-as-a-Service, and Asset Licensing. These collaborative efforts facilitate innovative advancements in drug discovery, leveraging state-of-the-art robotic facilities and comprehensive wet lab assays to bring new therapeutics to market.